Kyushu University Academic Staff Educational and Research Activities Database
Researcher information (To researchers) Need Help? How to update
Itoh Shinji Last modified date:2023.11.27

Lecturer / Department of Surgery and Science
Liver Surgery
Kyushu University Hospital




Homepage
https://kyushu-u.elsevierpure.com/en/persons/shinji-itoh
 Reseacher Profiling Tool Kyushu University Pure
Academic Degree
PhD
Country of degree conferring institution (Overseas)
Yes Doctor
Field of Specialization
Hepatobiliary and Pancreatic Surgery、Liver Transplantation
Research
Research Interests
  • Efficacy of liver resection
    keyword : liver resection
    2014.04.
  • Intratumoral heterogeneity in HBP malignancy
    keyword : heterogeneity
    2020.04.
  • Role of stress response in HBP malignancy
    keyword : liver cancer, biliary cancer, pancreatic cancer, stress response、nrf2、ferroptosis
    2016.04.
  • Immunooncology in HBP malignancy
    keyword : immunooncology, biomarker
    2017.04.
  • Cancer metabolism of HBP surgery
    keyword : cancer metabolism
    2016.04.
  • Role of microRNA on tumor progression in HBP surgery
    keyword : micro RNA
    2015.04.
  • Role of Sarcopenia and frailty in patients with liver disease or HBP malignancy
    keyword : sarcopenia, frailty, physical performance
    2015.04.
  • Functional Remnant Liver Assessment Predicts Liver-Related Morbidity after Hepatic Resection in Patients with Hepatocellular Carcinoma
    keyword : Functional remnant liver assessment, morbidity, hepatic resection
    2015.04.
  • Impact of liver transplantation on outcome
    keyword : liver transplantation
    2014.04.
Academic Activities
Papers
1. Itoh S, Toshida K, Morita K, Kurihara T, Nagao Y, Tomino T, Toshima T, Harada N, Mori M, Yoshizumi T., Clinical effectiveness of surgical treatment after lenvatinib administration for hepatocellular carcinoma., Int J Clin Oncol. , 2022.11.
2. Itoh, Shinji; Yoshizumi, Tomoharu; Kitamura, Yoshiyuki; Yugawa, Kyohei; Iseda, Norifumi; Shimagaki, Tomonari; Nagao, Yoshihiro; Toshima, Takeo; Harada, Noboru; Kohashi, Kenichi; Baba, Shingo; Ishigami, Kousei; Oda, Yoshinao; Mori, Masaki, Impact of Metabolic Activity in Hepatocellular Carcinoma: Association With Immune Status and Vascular Formation, HEPATOLOGY COMMUNICATIONS, 10.1002/hep4.1715, 2021.03.
3. Itoh, Shinji; Yoshizumi, Tomoharu; Yugawa, Kyohei; Imai, Daisuke; Yoshiya, Shohei; Takeishi, Kazuki; Toshima, Takeo; Harada, Noboru; Ikegami, Toru; Soejima, Yuji; Kohashi, Kenichi; Oda, Yoshinao; Mori, Masaki, Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation, HEPATOLOGY, 10.1002/hep.31206, 72, 6, 1987-1999, 2020.12.
Presentations
1. Shinji Itoh, Katsuya Toshida, Takahiro Tomiyama, Akinari Morinaga, Yukiko Kosai, Takahiro Tomino, Takeshi Kurihara, Yoshihiro Nagao, Kazutoyo Morita, Noboru Harada, Tomoharu Yoshizumi, Multidisciplinary treatment in HCC: Impact of surgery after multi-molecular target agent, The 34th Meeting of Japanese Society of Hepato-Biliary-Pancreatic Surgery, 2022.06.
2. Shinji Itoh、Tomoharu Yoshizumi、Norifumi Iseda、Tomonari Shibagaki、 Huanlin Wang、Takeshi Kurihara、Yoshihiro Nagao、Takeo Toshima、 Noboru Harada、Masaki Mori, Future perspectives of multidisciplinary treatment in HCC: Association with immune microenvironment, 第76回日本消化器外科学会総会, 2021.07.
3. Itoh S, Yoshizumi T, Imai D, Yoshiya S, Takeishi K, Harada N, Ikegami T, Mori M, Recent treatment strategies for HCC -non-surgical treatment, resection and transplantation-, The 31st Meeting of Japanese Society of Hepato-Biliary-Pancreatic Sugery, 2019.06.
4. Itoh S, Yoshizumi T, Shimokawa M, Mano Y, Motomura T, Toshima T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y, Lymphocyte-to-monocyte ratio is associated with PD-L1 expression on tumor progression in hepatocellular carcinoma, 第28回日本消化器癌発生学会総会, 2017.11.
5. Itoh S, Yoshizumi T, Nagatsu A, Motomura T, Harada N, Harimoto N, Ikegami T, Soejima Y, Ikeda T, Kamishima T, Maehara Y , Relationship between skeletal muscle mass assessed by computed tomography and muscle strength in patients with liver disease., 40th World Congress of the International College of Surgeons, 2016.10.
6. Itoh S, Yoshizumi T, Harimoto N, Kimura K, Okabe H, Harada N, Ikegami T, Uchiyama H, Ikeda T, Maehara Y, Surgical treatment of hepatocellular carcinoma with macroscopic portal venous tumor thrombus, 第71回日本消化器外科学会総会, 2016.07.
7. Shinji Itoh, Ken Shirabe, Koichi Kimura, Hironao Okabe, Norifumi Harimoto, Toru Ikegami, Hideaki Uchiyama, Tomoharu Yoshizumi, Tetsuo Ikeda, Yoshihiko Maehara, Phase I study of sorafenib in combination with uracil-tegafur in patients with unresectable advanced hepatocellular carcinoma in Japan, ESMO Asia 2015 Congress, 2015.12.